MENA Syringes & Cannula

MENA Syringes & Cannula

Syringes are medical instruments for injecting or withdrawing fluid into or out of the body and they typically have a barrel, plunger, and a needle. Cannulas are thin, flexible tubes used to inject substances into the veins or body cavities or used to remove fluids. Adding to this, the increased rate of diabetes, cardiovascular diseases, and other chronic diseases led to other increased frequency of standard medical procedures.

The MENA Syringes & Cannula Market is expected to grow at a robust CAGR of 7.29% during the forecast period (2024-2032). Owing to the aging population is more vulnerable to illnesses that require hospitalization and medical procedures that involve syringes and cannula. As per the United Nations Population Fund (UNFPA), in 2024, the United Arab Emirates is going through a demographic transition as the number of persons aged 60+ is expected to increase more than six-fold between 2020 - 2050 from about 311,000 (3.1% of the total population) to 2 million (19.7%). Furthermore, the use of devices like cannula for surgeries and treatments has increased as medical procedures have become more advanced.

• Based on the product, the market is segmented into syringes and cannula. Among them, the Cannula is expected to grow with a significant CAGR during the forecast period (2024-2032). As the population grows older or develops certain diseases associated with lifestyles, diseases like cardiovascular diseases call for angiography and other forms of cardiac interventional procedures that require the use of cannulas, hence creating demands. This growth is complemented by the region's aging population, where elderly people need more medical treatment than other ages, which often involves cannulas. Thus, market growth is fostered by the demand for cannulas in the syringes & cannulas market.
• Based on the usage, the market is segmented into reusable and disposable. Among them, Disposable held a dominant market share in 2023. This is mainly due to increased awareness of infection control and an increase in the incidence of chronic diseases that necessitate the use of injections. In 2022, the National Institute of Health stated that there were 463,675 new cancer cases estimated to be in Arab countries, corresponding to 2.4% of the global incidence. Due to the disposable nature of the syringes and cannulas, the chances of reusing the types of equipment or sharing the same amongst patients to cause infections are greatly minimized to promote patient safety.
• By distribution channel, the market is segmented into hospitals, diagnostic laboratories, skilled nursing facilities, and others. Hospitals held the largest market share in 2023. The surge in chronic diseases is boosting the demand for these medical consumables in hospital settings. The GCC had over 829 hospitals accommodating more than 119,679 beds as of 2020, in addition to many primary healthcare centers, medical clinics and laboratories, as per the Health Ministries of GCC countries. Moreover, the push towards improving healthcare quality standards in the region encourages hospitals to use advanced, disposable syringes and cannulas to ensure patient safety and prevent cross-contamination.
• For a better understanding of the market adoption of the syringes & cannula industry, the MENA market is analyzed based on its presence in countries such as UAE, Saudi Arabia, Egypt, Kuwait, and the Rest of the MENA. The UAE is expected to grow with a significant CAGR during the forecast period (2024-2032). The market of syringes and cannula in UAE is consequently driven by government initiatives to enhance healthcare and construct better healthcare facilities. The current government’s investment in health under Vision 2021 has emphasized quality health facilities that depend majorly on medical disposables for the overall safe course of medical practice. For instance, in October 2022, the Ministry of Industry and Advanced Technology (MoIAT) announced the signing of a pair of MoU worth Dh 260 million (USD 7 million) between major pharmaceutical companies and medical devices companies in the United Arab Emirates. The UAE has a well-developed healthcare sector featuring modern hospitals and clinics generating demand for superior medical consumables like syringes and cannula. In addition, the UAE is one of the prominent medical tourism destinations in the region, hosting patients from all corners of the world and adding to the demand for medical devices and supplies.
• Some of the major players operating in the market include BD, Terumo Europe NV, Thermo Fisher Scientific Inc., Nipro Europe Group Companies, Medtronic, B. Braun SE, Henke-Sass, Wolf GmbH, Hindustan Syringes & Medical Devices Ltd, Cardinal Health, Medline Industries, LP.